|
|||||
|
|
Low molecular weight chitooligosaccharide inhibits infection of SARS-CoV-2 in vitro |
|
| Authors: | Donghwan Jang Dagyum Lee Young Chul Shin Joong Su Lee Jihee Jung Sungweon Ryoo |
| Institution: | 1. Clinical Research Center, Masan National Tuberculosis Hospital, Changwon, Republic of Korea;2. Amicogen Inc., Jinju-si, Republic of Korea |
| Abstract: | |
| Keywords: | antiviral effect chitooligosaccharide COVID-19 natural treatment SARS-CoV-2 |